Entrepreneur with successful track record with multiple start-up companies, experienced in recruiting and supervising strong management teams.
Commercial executive, previously Head of Inflammatory diseases, Europe at Pfizer. UK, EMEA and Global experience in emerging and established, biotech and pharmaceutical sectors, including pre-IPO. Demonstrable track record of building and leading commercial, access and medical teams to create and execute portfolio strategy.
Veterinarian with extensive research interests in pharmacognosy specifically focused on immunomodulatory phytochemicals and the roles they play in inflammation and the resolution of inflammation.
35 years experience in the pharma industry. Former Regulatory Affairs Manager, Lederle Laboratories before becoming Licensing & Acquisition Manager, Lederle Laboratories. Currently GM Subiaco Associates Ltd, Healthcare Regulatory Consultancy.
Professor of Primary Care Respiratory Medicine at the University of Aberdeen, UK. He is extensively involved in respiratory and allergy research, having published more than 300 peer-reviewed publications. A member of the editorial board of the Lancet Respiratory Medicine and Respiratory Research journals.
Former Chairman and MD of Sanofi UK. 40 years experience in the pharma industry. He holds several Academic, Charity and Life Sciences Chairmanships and Senior Board positions, which include Porton Down, the Clinical Trials Unit at Imperial College London and advising the Wellcome Trust.